Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Santin-Janin H, Mulder GJ, Bartholmai B, Gupta R, Richeldi L. Raghu G, et al. Among authors: golden ja. JAMA. 2018 Jun 12;319(22):2299-2307. doi: 10.1001/jama.2018.6129. JAMA. 2018. PMID: 29800034 Free PMC article. Clinical Trial.
Does chronic microaspiration cause idiopathic pulmonary fibrosis?
Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM, Golden JA, King TE Jr. Lee JS, et al. Among authors: golden ja. Am J Med. 2010 Apr;123(4):304-11. doi: 10.1016/j.amjmed.2009.07.033. Am J Med. 2010. PMID: 20362747 Free PMC article. Review.
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis.
Assayag D, Vittinghoff E, Ryerson CJ, Cocconcelli E, Tonelli R, Hu X, Elicker BM, Golden JA, Jones KD, King TE Jr, Koth LL, Lee JS, Ley B, Shum AK, Wolters PJ, Ryu JH, Collard HR. Assayag D, et al. Among authors: golden ja. Respir Med. 2015 Aug;109(8):1058-62. doi: 10.1016/j.rmed.2015.06.012. Epub 2015 Jun 24. Respir Med. 2015. PMID: 26140806 Free PMC article.
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Moran D, Santin-Janin H, Aubin F, Mulder GJ, Gupta R, Richeldi L. Raghu G, et al. Among authors: golden ja. Lancet Respir Med. 2019 Aug;7(8):657-664. doi: 10.1016/S2213-2600(19)30172-9. Epub 2019 May 20. Lancet Respir Med. 2019. PMID: 31122893 Clinical Trial.
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study.
Raghu G, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Burgess T, Kamath N, Donaldson F, Richeldi L. Raghu G, et al. Among authors: golden ja. Respir Res. 2022 May 21;23(1):129. doi: 10.1186/s12931-022-02047-0. Respir Res. 2022. PMID: 35597980 Free PMC article. Clinical Trial.
Idiopathic pulmonary fibrosis: how often is it really idiopathic?
Patti MG, Tedesco P, Golden J, Hays S, Hoopes C, Meneghetti A, Damani T, Way LW. Patti MG, et al. J Gastrointest Surg. 2005 Nov;9(8):1053-6; discussion 1056-8. doi: 10.1016/j.gassur.2005.06.027. J Gastrointest Surg. 2005. PMID: 16269375
Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis.
Marmai C, Sutherland RE, Kim KK, Dolganov GM, Fang X, Kim SS, Jiang S, Golden JA, Hoopes CW, Matthay MA, Chapman HA, Wolters PJ. Marmai C, et al. Among authors: golden ja. Am J Physiol Lung Cell Mol Physiol. 2011 Jul;301(1):L71-8. doi: 10.1152/ajplung.00212.2010. Epub 2011 Apr 15. Am J Physiol Lung Cell Mol Physiol. 2011. PMID: 21498628 Free PMC article.
327 results